Loading...

bioAffinity Technologies, Inc.

BIAF•NASDAQ
Healthcare
Medical - Diagnostics & Research
$2.23
$-0.07(-3.04%)
U.S. Market opens in 23h 5m

bioAffinity Technologies, Inc. (BIAF) Stock Overview

Explore bioAffinity Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap10M
P/E Ratio-0.26
EPS (TTM)$-8.66
ROE-3.85%
Fundamental Analysis

AI Price Forecasts

1 Month$1.51
3 Months$1.92
1 Year Target$0.84

BIAF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of bioAffinity Technologies, Inc. (BIAF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.84.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.26 and a market capitalization of 10M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.04%
5-Day Change
-21.48%
1-Month Change
-43.69%
3-Month Change
65.19%
6-Month Change
-15.85%
Year-to-Date (YTD) Change
88.98%
1-Year Change
-85.48%
3-Year Change
-96.37%
5-Year Change
-99.10%
All-Time (Max) Change
-99.10%

Contact Information

https://www.bioaffinitytech.com
210 698 5334
22211 West Interstate 10, San Antonio, TX, 78257

Company Facts

57 Employees
IPO DateSep 1, 2022
CountryUS
Actively Trading

Frequently Asked Questions